검색
CorMedix Inc
CRMD관심 목록에 추가
8.750USD
+0.280+3.31%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
686.45M시가총액
3.60P/E TTM
자세한 내용은 CorMedix Inc 회사
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
CorMedix Inc 정보
종목 코드 CRMD
회사 이름CorMedix Inc
상장일Mar 25, 2010
CEOTodisco (Joseph)
직원 수64
유형Ordinary Share
회계 연도 종료Mar 25
주소300 Connell Drive
도시BERKELEY HEIGHTS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07922
전화19085179500
웹사이트https://cormedix.com/
종목 코드 CRMD
상장일Mar 25, 2010
CEOTodisco (Joseph)
CorMedix Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
401.08K
-41.48%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+47.50%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
38.47K
-14.17%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
38.33K
-14.23%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
36.00K
-15.15%
Mr. Myron M. Kaplan, J.D.
Mr. Myron M. Kaplan, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Ms. Elizabeth (Liz) Massonhurlburt
Ms. Elizabeth (Liz) Massonhurlburt
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Matthew T. (Matt) David, M.D.
Dr. Matthew T. (Matt) David, M.D.
Chief Business Officer
Chief Business Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
401.08K
-41.48%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+47.50%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
38.47K
-14.17%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
38.33K
-14.23%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
36.00K
-15.15%
자주 묻는 질문
CorMedix Inc의 상위 5대 주주는 누구인가요?
CorMedix Inc의 상위 5대 주주는 다음과 같습니다: Mr. Joseph (Joe) Todisco
CorMedix Inc(CRMD)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, CorMedix Inc의 주식을 보유한 기관은 총 390곳이며, 이들이 보유한 주식의 총 가치는 약 43.28M로 전체 발행 주식의 55.17%를 차지합니다. 이는 2025Q4 대비 -18630389.00 증가한 수치입니다.